Gz, a guanine nucleotide-binding protein with unique biochemical properties by Casey, Patrick J. et al.
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
0 1990 by The American Society for Biochemistry and Molecular Biology, Inc. 
Vol. 265, No. 4, Issue of February 5, pp. 2383-2390,lSSO 
Printed in U.S.A. 
G,, a Guanine Nucleotide-binding Protein with Unique Biochemical 
Properties* 
(Received for publication, August 9, 1989) 
Patrick J. Casey& Henry K. W. FongQ7, Melvin I. Simonlj, and Alfred G. Gilman+** 
From the *Department of Pharmacology, University of Texas Southwestern Medical Center, Da&s, Texas 75235, the 
SDepartments of Ophthalmology and Microbiology, University of Southern California School of Medicine, 
Los Angeles, California 90033, and the [IDepartment of Biology, California Institute of Technology, Pasadena, California 91125 
Cloning of a complementary DNA (cDNA) for G,, a 
newly apprecitated member of the family of guanine 
nucleotide-binding regulatory proteins (G proteins), 
has allowed preparation of specific antisera to identify 
the protein in tissues and to assay it during purification 
from bovine brain. Additionally, expression of the 
cDNA in Escherichia coli has resulted in the production 
and purification of the recombinant protein. 
Purification of G, from bovine brain is tedious, and 
only small quantities of protein have been obtained. 
The protein copurifies with the 87 subunit complex 
common to other G proteins; another 26-kDa GTP- 
binding protein is also present in these preparations. 
The purified protein could not serve as a substrate for 
NAD-dependent ADP-ribosylation catalyzed by either 
pertussis toxin or cholera toxin. 
Purification of recombinant G, (rG,,) from E. coli is 
simple, and quantities of homogeneous protein suffi- 
cient for biochemical analysis are obtained. Purified 
rG, has several properties that distinguish it from 
other G protein (Y subunit polypeptides. These include 
a very slow rate of guanine nucleotide exchange (k = 
0.02 min-‘), which is reduced >20-fold in the presence 
of mM concentrations of Mg’+. In addition, the rate of 
the intrinsic GTPase activity of G,, is extremely slow. 
The hydrolysis rate (k,.J for rG,, at 30 “C is 0.05 min-‘, 
or 200-fold slower than that determined for other G 
protein LY subunits. rGza can interact with bovine brain 
pr but does not serve as a substrate for ADP-ribosyla- 
tion catalyzed by either pertussis toxin or cholera 
toxin. These studies suggest that G, may play a role in 
signal transduction pathways that are mechanistically 
distinct from those controlled by the other members of 
the G protein family. 
Guanine nucleotide-binding regulatory proteins (G pro- 
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teins)’ control an array of cellular ptocesses by modulating 
the concentrations of crucial second messengers within the 
cell (1, 2). Members of this family of proteins function by 
means of their ability to control the activity of effecters such 
as adenylyl cyclase, cGMP phosphodiesterase, phospholi- 
pases, and ion channels in response to activation by specific 
membrane receptors. G proteins share a heterotrimeric struc- 
ture, with subunits designated (Y, /3, and y. G protein oligomers 
are classified by the identity of their distinct (Y subunit, 
although multiple forms of the p (3, 4) and y (5, 6) subunits 
exist as well. These proteins function via a cycle of subunit 
(a.&) dissociation, superimposed upon a cycle of receptor- 
stimulated guanine nucleotide exchange. Thus, a specific ag- 
onist-receptor complex catalyzes the exchange of GDP bound 
to the (Y subunit for GTP; the (Y. GTP complex dissociates 
from fir and interacts with (regulates) its respective effecters. 
Deactivation results from hydrolysis of protein-bound GTP 
and association of (Y. GDP with Dr. The Pr complex may also 
regulate effecters directly (7), although this issue is still 
controversial. 
The G protein family accommodates an increasing number 
(>9) of highly homologous but distinct (Y subunits (2, 8). A 
major focus is to identify the specific functions of these 
proteins, some of which are known only as cDNAs. The 
availability of Escherichia coli expression systems capable of 
producing active protein from these cDNAs has provided a 
means to evaluate and compare the characteristics of the 
individual members of this family (9, lo).* 
The G protein 01 subunits characterized to date contain 
sites for NAD-dependent ADP-ribosylation that is catalyzed 
by bacterial toxins. G,, can be ADP-ribosylated by cholera 
toxin; G,, and the cy subunits of the Gis can be modified by 
pertussis toxin; and Gt, can serve as a substrate for both 
toxins (11, 12). Modification of G proteins by these toxins 
results in characteristic alterations of their function (13, 14). 
Thus, these toxins have been extremely useful for delineating 
signaling pathways that are under control of G proteins. 
However, several such pathways respond to guanine nucleo- 
tides but are insensitive to treatment of cells with cholera or 
pertussis toxin. A great deal of interest has been focused on 
GTP-dependent pertussis toxin-insensitive events; these in- 
clude hormonal regulation of phosphoinositide-specific phos- 
1 The abbreviations used are: G proteins, guanine nucleotide-bind- 
ing regulatory proteins; G. and Gi, G proteins that mediate stimula- 
tion and inhibition of adenylyl cyclase, respectively; G,, a G protein 
abundant in brain; G, the predominant G protein in retina; G,, a G 
protein of unknown function; G,, example of nomenclature to des- 
ignate the 01 subunit of G,; rG,, and rG.,, recombinant G,, and G.,; 
GTPrS, guanosine 5’-3-0-(thio)triphosphate; SDS, sodium dodecyl 
sulfate; PAGE, polyacrylamide gel electrophoresis; Hepes, 4-(2-hy- 
droxyethyl)-l-piperazineethanesulfonic acid; DTT, dithiothreitol. 
’ M. Linder and A. G. Gilman, unpublished observations. 
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2384 Properties of G, 
pholipase C in several tissues (l&16) and regulation of certain 
ion channels (17). These observations have prompted specu- 
lation on the existence of G proteins that are refractory to 
modification by these bacterial toxins. 
Fong and colleagues (18) and Matsuoka and associates (19) 
recently isolated a cDNA that encodes a unique G protein (Y 
subunit (termed G, or G,). RNA blot hybridization analysis 
showed that the gene for this LY subunit is transcribed predom- 
inantly in neural tissues. The deduced amino acid sequence 
of the protein resembles that of the Gi, subunits, but it has 
differences in two particularly notable regions. First, the 
cysteine residue near the carboxyl terminus that serves as the 
site for pertussis toxin-catalyzed ADP-ribosylation is not 
present. Thus, this protein is a candidate for involvement in 
the GTP-dependent pertussis toxin-insensitive events noted 
above. Second, 3 amino acid residues in the first portion of 
the guanine nucleotide-binding domain differ from those that 
are strictly conserved in all other known (Y subunits. Struc- 
tural studies on the GTP-binding proteins elongation factor 
Tu (20) and rm (21, 22) suggest that this region is involved 
in the catalytic step of GTP hydrolysis, and mutations in this 
region of ras (23) and G,,( (24) cause significant changes in 
the rate of nucleotide hydrolysis. We undertook purification 
of this protein in order to determine its properties and to 
search for its functions. 
EXPERIMENTAL PROCEDURES 
Preparation of Membranes, G Proteins, and Subunits-Bovine 
brain membranes were prepared as described by Sternweis and Rob- 
ishaw (25) and stored at a protein concentration of 20 mg/ml at 
-70°C until use. Membranes from other tissues were prepared as 
described (26). Bovine brain G proteins (25) and their resolved o( and 
/3r subunits (27,28) were purified by established procedures. The 52- 
kDa form of recombinant G,,, (rG,,), purified after expression in E. 
coli (lo), was a gift of Dr. Michael Freissmuth (University of Vienna). 
ADP-ribosylation factor was a gift of Dr. Richard Kahn (National 
Cancer Institute). 
Production of Antisera-Peptides to be utilized as antigens (see 
Table I) were synthesized according to amino acid sequences deduced 
from the human G,, cDNA (18). The peptides were cross-linked to 
keyhole limpet hemocyanin (Sigma) with m-maleimidobenzoyl N- 
hydroxysuccinimide ester (29). Rabbits were immunized with the 
peptide-protein conjugates as described previously (30). Rabbits de- 
veloped antibody titers to peptide and G,, protein as assayed by 
enzyme-linked immunoassay and immunoblotting, respectively. An- 
tibodies to peptide P-961 were purified from the antisera by affinity 
chromatography using a column of peptide (3 mg) coupled to CNBr- 
activated Sepharose 6MB (1 ml, Pharmacia LKB Biotechnology Inc.) 
as described (26). Immunoblots were processed as described previ- 
ously (30) except that ‘251-labeled goat anti-rabbit IgG F(ab’)z frag- 
ments (Du Pont-New England Nuclear) were used as the secondary 
antibody. Antisera A-569 and U-49 were a gift of Dr. Susanne Mumby 
(University of Texas Southwestern Medical Center) (30). 
Purification of G, from Bovine Bruin-Bovine brain membranes 
(12 g of protein) were washed and extracted with 1% sodium cholate 
(25). The 100,000 X g supernatant (extract) was supplemented with 
AlC13 (20 FM), MgCl, (6 mM), and NaF (10 mM) (AMF). This solution 
was applied to a l.O-liter column of DEAE-Sephacel which had been 
TABLE I 
G,, sequences used for generation of antipeptide antisera 
Peptides were synthesized with a cysteine at the amino terminus 
to facilitate coupling to keyhole limpet hemocyanin. Specificity of 
reactivity was determined by immunoblotting using the indicated 
purified proteins. NT, not tested. Number of + denotes intensity of 
resnonse: - denotes no reaction. 
Sequence Designation a, ni.. a. a, 
CRQSSEEKEAARRSRR Gz.3 ++ - - NT 
CRQSSEEKEAARRSRR P-961 ++++ - - NT 
CGTSNSGKSTIVKQMK P-960 ++ ++++ ++ ++ 
CTGPAESKGEITPELL G,.,,, +++ - - NT 
equilibrated with 3 liters of 20 mM Tris-Cl (pH 8.0), 1 mM EDTA, 1 
mM DTT, 1% sodium cholate, and AMF (buffer 1). The column was 
washed with 250 ml of buffer 1 and eluted with a 2-liter linear gradient 
of NaCl (O-500 mM) in the same buffer. Fractions of 24 ml were 
collected, beginning with the start of the gradient. The column was 
assayed for G, by immunoblot analysis of 12-~1 aliquots of the 
fractions with antiserum Gzmlll. G, eluted from this column in a broad 
peak centered at 200 mM NaCl. The peak fractions from the DEAE 
column were pooled and concentrated to 30 ml by pressure filtration 
through an Amicon PM-30 membrane. This material was applied to 
a 1.2-liter column of Ultrogel AcA 34 (LKB), equilibrated in buffer 1 
containing 100 mM NaCl, and the column was eluted with the same 
buffer. Fractions of 14 ml were collected. G,, immunoreactivity eluted 
in a symmetrical peak centered at 670 ml. The fractions were pooled, 
concentrated to 30 ml as above, and diluted to 200 ml with buffer 1 
(with 0.1% sodium cholate) containing 400 mM NaCl. This sample 
was applied to a loo-ml column of heptylamine-Sepharose, equili- 
brated in the same buffer. The column was washed with 50 ml of 
buffer 1 (with 0.3% sodium cholate) containing 400 mM NaCl and 
was eluted with a 600-ml linear gradient (NaCI decreasing to 0 and 
sodium cholate increasing to 1.2% in buffer 1); fractions of 8 ml were 
collected. G,, immunoreactivity eluted in a broad peak centered at 
425 ml into the gradient. The peak fractions were pooled and concen- 
trated to 2 ml, and the buffer was changed to buffer 1 (without AMF) 
by three successive dilutions to 10 ml and concentrations to 2 ml. 
The pool was then diluted to 10 ml with 10 mM Tris-Cl, 10 mM 
potassium phosphate (pH 8.0), 1 mM DTT, 1.0% sodium cholate, and 
10 pM GDP (buffer 2). This sample was applied to a Bio-Rad high 
performance hydroxylapatite column; the column fittings were 
adapted to allow use with the Pharmacia fast protein liquid chroma- 
tography system. The column was washed with 5 ml of buffer 2 and 
eluted with a 22-ml linear gradient to 100 mM potassium phosphate, 
pH 8.0, in the same buffer; fractions of 0.75 ml were collected. G,, 
immunoreactivity eluted at 80 mM potassium phosphate. (G,, can 
also be visualized as a 40-kDa protein on silver-stained gels at this 
point.) The peak fractions were pooled and concentrated to 1 ml, a?d 
the buffer was changed to buffer 1 (0.4% sodium cholate) containing 
1.0 M ammonium sulfate and 20 pM GDP (buffer 3) by successive 
dilution and concentration as described above. The diluted sample 
(10 ml) was applied to a phenyl-Superose fast protein liquid chro- 
matography column (0.5 X 5.0 cm) (Pharmacia). The column was 
washed with 5 ml of buffer 3 and eluted with a 20-ml linear gradient 
of ammonium sulfate decreasing to 0 in the same buffer. G,, eluted 
in a broad peak at 6-10 ml into the gradient as a 40-kDa immuno- 
reactive protein accompanied by a 35/36-kDa doublet identified im- 
munologically as the p subunits of G proteins (see Fig. 1). A protein 
of 26 kDa was also apparent if more protein was applied to the gel, 
and the gel was stained with Coomassie Blue (see “Results”). The 
fractions containing G, were pooled and concentrated to 0.2 ml using 
a Centricon 30 (Amicon), and the buffer was changed to buffer 1 
containing 20% glycerol by three successive dilutions to 2 ml and 
STAIN %-I 11 S-3 A-569 u-49 
Gi GZ Gi Gz Gi G, Gi G, Gi G7 
FIG. 1. SDS-polyacrylamide gel electrophoresis and immu- 
noblot analysis of purified bovine brain G.. Each panel consists 
of two lanes in which 150 ng each of either Gi or G, purified from 
bovine brain was resolved on 11% polyacrylamide gels. The left panel 
is a silver stain of the proteins; the y subunit ran with the dye front 
on this gel and is not visualized. The remaining panels are immuno- 
blots using the indicated antisera. Antisera Gz-lll and G.-S were raised 
to peptide sequences unique to G, (see Table I); A-569 is a “common” 
LY antiserum (30) that recognizes all G protein LY subunits except that 
of G,, and U-49 is an anti-@ antiserum (30). 
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Properties of G, 
concentrations to 0.2 ml. The final preparation was stored at -70 “C. 
A summary of the purifications is shown in Tables II and III. 
Construction of G, Expression Vector-Plasmid PBS-G,, which 
contains the complete coding sequence of human G,, (18), was si- 
multaneously cleaved with NcoI and P&I, and the insert was purified 
by agarose gel electrophoresis. The NcoI-PstI fragment was ligated 
with plasmid NpT7-5 (10) after digestion of that plasmid with the 
same two restriction enzymes. Transformation of E. coli strain BL- 
21/DE3 (31) with the resulting plasmid (referred to as NpT7-5/G,) 
resulted in the isopropyl @-D-thiogalactopyranoside-inducible expres- 
sion of immunoreactive recombinant G,, (rG,,) in these cells. E. coli 
strain BL-21/DE3 is a T7 lysogen in which the gene for the T7 
polymerase is driven by the lac UV-5 promoter. 
Purification of rG,,-One hundred liters of LB medium was inoc- 
ulated with BL-21/DE3 harboring plasmid NpT7-5/G, and incubated 
in a fermenter at 30°C to an OD of 1.5. Expression of rG,, was 
induced by the addition of isopropyl P-D-thiogalactopyranoside (0.4 
mM), and the incubation was continued for another 3 h. The cells 
were harvested with a continuous flow centrifuge, and the resulting 
cell paste (350 g) was frozen in liquid Nz and stored at -70 “C. 
rG, was purified from 50 g of cell paste. The paste was diluted 
with 80 ml of 50 mM Hepes (pH 7.5), 1 mM EDTA, and 1 mM DTT 
(buffer 4) containing 0.2 mM phenylmethylsulfonyl fluoride, 0.5 mM 
N-tosyl-L-phenylalanine chloromethyl ketone, and 0.5 mM Na-p- 
tosyl-L-lysine chloromethyl ketone, and the slurry was processed 
through a French pressure cell at 20,000 p.s.i. to lyse the cells. The 
mixture was diluted to 1.4 liters with buffer 4 containing 0.2 mM 
phenylmethylsulfonyl fluoride and centrifuged at 30,000 x g for 90 
min. The supernatant was decanted, supplemented with GDP (50 
PM), and loaded onto a 5.5 X 5.0-cm column of S-Sepharose Fast-F10 
(Pharmacia). The column was washed with 50 ml of buffer 4 and 
eluted with a 600-ml linear gradient of NaCl (O-l,000 mM) in buffer 
4 containing 5 mM MgCl,. rG,, eluted from this column at 300 mM 
NaCl as judged by immunoblots using antiserum P-961 (a distinct 
peak of GTPyS-binding activity was also observed). The peak frac- 
tions were pooled, concentrated to 25 ml, and dialyzed against 15 mM 
Tris-Cl (pH 8.0), 0.1 mM EDTA, 1 mM DTT, and 3 mM MgC12 (buffer 
5) for 15 h (three changes, 2 liters each). A considerable amount of 
precipitate formed during the dialysis; this was removed by centrifu- 
gation at 30,000 x g for 30 min. The supernatant was loaded onto a 
fast protein liquid chromatography Mono Q HRlO/lO column (Phar- 
macia), which was then washed with 50 ml of buffer 5 and eluted 
with a loo-ml gradient of NaCl (O-250 mM) in the same buffer. The 
main peaks of both P-961 immunoreactivity and GTPyS-binding 
activity coeluted from this column at 50 XnM NaCl, SDS-PAGE 
analysis of column fractions revealed that the predominant protein 
in this peak migrated at 40 kDa (see Fig. 3). The peak fractions were 
pooled, supplemented with 1 M Hepes, pH 7.5, to a final concentration 
of 50 mM, and injected onto a Mono S HR5/5 column (Pharmacia). 
TABLE II 
Purification of G, from bovine brain membranes 
step Volume Protein GTPrS binding” 
ml w nmol nmol. mg protein-’ 
Cholate extract 1600 4500 1600 0.35 
DEAE 30 300 70 0.23 
AcA 34 8 70 7.5 0.11 
c-7 10 6 1.5 0.25 
HPHTb 10 2 1.0 0.50 
Phenyl-Superose 0.38 0.06 0.25 4.20 
“Other g-uanine nucleotide-binding proteins are present in the 
initial extract. 
* HPHT, high performance hydroxylapatite. 
TABLE III 
Purification of recombinant G,, 
step Volume Protein GTP-yS binding” 
ml w nmol nmol. mg protein-’ 
Soluble lysate 1400 3500 170 0.05 
S-Sepharose 53 43 15 0.35 
Mono Q 3.0 0.56 5.1 9.1 
Mono S 5.0 0.34 4.8 14.1 
“Other guanine nucleotide-binding proteins are present in the 
soluble lysate. 
This column was then washed with 5 ml of buffer 4 (with 5 mM 
MgCl,) and eluted with a gradient of NaCl (O-500 mM) in the same 
buffer. Fig. 2 shows the protein, GTPy S-binding profile, and gradient 
conditions of this chromatographic step. The main protein peak and 
the sole peak of GTPyS-binding activity comigrated at 300 mM NaCl. 
SDS-PAGE analysis of the fractions across this peak revealed a single 
40-kDa polypeptide. The peak fractions were pooled and supple- 
mented with 1 mg of bovine serum albumin, and the buffer was 
changed to buffer 4 (with 5 mM MgClz) by concentration and dilution. 
The final sample (400 ~1) was stored at -70°C. A summary of the 
purifications is shown in Tables II and III, and SDS-PAGE analysis 
of the pools obtained from each chromatographic step is shown in 
Fig. 3. 
This purification scheme was carried out once after supplementa- 
tion of the extract with 5 mM MgCl, prior to chromatography on S- 
Sepharose. The column elution profiles of G, during this procedure 
were essentially identical to those described above, except for the 
final step. Here, G, eluted as a doublet of both protein and GTPrS- 
0.40 
I 
I 
* 0.05 
0 
0.25 
Fraction Number 
FIG. 2. Mono S chromatography of rG,. Details are under 
“Experimental Procedures.” The mono Q pool obtained in the puri- 
fication of rG,, was chromatographed on the mono S column as the 
last step in the purification. The full plot is the protein profile and 
gradient conditions for the elution. The inset shows the GTPrS- 
binding activity (conducted at 500 nM free Mg2+) of selected fractions. 
12345 
40kDo- 
.^* - . . ..I _ 
- 
-rr 
FIG. 3. SDS-polyacrylamide gel electrophoresis analysis of 
rG, purification. Aliquots of fractions from the various stages in 
the purification of rG,, were resolved by SDS-PAGE on an 11% 
polyacrylamide gel, and proteins were visualized by staining with 
Coomassie Blue. Lane I, 35 rg of the soluble lysate from the E. coli 
expression system; lane 2, 7 pg from the S-Sepharose pool; lane 3,0.6 
fig from the mono Q pool; he 4,0.50 pg from the mono S pool; he 
5, 1.5 pg from the mono S pool. Apparent molecular mass was 
determined from the migration of protein standards resolved on the 
same gel. 
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Properties of G, 
binding activity. SDS-PAGE analysis of the fractions across these 
peaks revealed that the first (eluting at 280 mM NaCl) was composed 
of a 39-kDa protein (mono-S:l), whereas the second (eluting at 300 
mM NaCl) was a 40-kDA species (mono-S:2). SDS-PAGE and im- 
munoblot analysis of fractions from this purification are shown in 
Fig. 4. These studies revealed that the 39-kDa polypeptide is almost 
certainly derived from the 40-kDa species by removal of the amino 
terminus since the G,,.-specific antiserum raised to a peptide from an 
internal sequence (P-960) recognized both polypeptides, whereas the 
antiserum raised to the amino-terminal sequence (P-961) recognized 
only the IO-kDa form. 
Miscellaneous Methods-Guanine nucleotide binding to G proteins 
was quantitated as described previously (32). All measurements were 
made at 30°C. The standard incubation mixture contained 50 mM 
Hepes (pH 7.6), 1 mM EDTA, 1 mM DTT (HED), 0.05% Lubrol, and 
0.5 pM guanine nucleotide ([35S]GTP+, [~u-~*P]GTP, or [r-““P] 
GTP). Reactions were terminated by the addition of 0.5 ml of ice- 
cold 20 mM Tris-Cl (pH 8.0), 100 mM NaCl, 20 mM MgCl*, and 50 
FM GTP, and the tubes were held on ice until filtration. Mg2 
concentrations in the individual experiments are noted in the figure 
legends; free MgZ+ was calculated using a Kd of EDTA for Mg2+ at 
pH 7.6 of 1 pM (33). Since all experiments were carried out with at 
least 1 mM EDTA present, the chelating effect of the guanine nucleo- 
tide was assumed to be negligible. Data from experiments designed 
to measure the rate of association of nucleotide with protein were 
analyzed by fitting to a first-order kinetic model. GTPase activity 
was measured as described (34), using the same incubation mixture 
and conditions described for guanine nucleotide binding. Estimates 
of the rate of the catalytic step (k,,,) of the GTPase reaction catalyzed 
by rG,,, were obtained by fitting data to the following model (34) 
where G is the total concentration of G protein, &is the rate constant 
for GDP dissociation from (or GTP-yS binding to) the G protein, and 
t is time. 
Pertussis toxin-catalyzed ADP-ribosylation of G proteins was con- 
ducted as described (28). Briefly, proteins were suspended in 40 ~1 of 
75 mM Tris-Cl (KIH 8.0). 1 mM EDTA. 1 mM M&L. 10 KM GDP. 2 
mM DTT, 2.5 & NAD; [“‘PINAD (l&O00 cpmy/piol), ‘0.5 mM di- 
myristoylphosphatidyl choline, and 5 fig/ml of pertussis toxin (List 
Biologicals). Incubations were for 2 h at 2O’C. Cholera toxin-cata- 
lyzed ADP-ribosylation was performed as described by Kahn and 
Gilman (35). Proteins were mixed with bovine ADP-ribosylation 
factor and the other components of the reaction mixture (35); acti- 
vated cholera toxin (Calbiochem) was added to a final concentration 
of 40 pg/ml, and the samples were incubated for 2 h at 20 “C. Details 
are provided in the legend to Fig. 8. SDS-PAGE was performed by 
PROTEIN STAIN P-960 P-961 
I I I 
CJ- I z 5 
I 
- =zzz-- 
Ilr 
FIG. 4. SDS-polyacrylamide gel electrophoresis and immu- 
noblot analysis of rG, fractions from purification scheme that 
included Mg2+ in the extract. Samples were resolved by SDS- 
PAGE on 11% polyacrylamide gels. Left panel, Coomassie Blue stain 
of a mixture of Gi and G,, (G&) in which the (Y (39-41 kDa) and a 
(35-36 kDa) subunits are visualized. In the next three lanes, aliquots 
of 250 ng each of the mono Q pool, mono S pool 1 (clipped rG,,), and 
mono S pool 2 (intact rG,,) were processed. The center and right 
panels are immunoblot analyses of the mono Q and two mono S pools 
using P-960 (antiserum raised to internal peptide) and P-961 (anti- 
serum raised to amino-terminal peptide), respectively. 
the method of Laemmli (36). Protein was quantitated by dye binding 
(37) (Bio-Rad). 
RESULTS 
Bovine Brain G,-An initial screening of bovine tissues by 
immunoblot analysis using antiserum Gz-lll revealed detect- 
able levels of a 40-kDa immunoreactive protein in membranes 
derived from brain and adrenal medulla (results not shown). 
We also observed significant amounts of immunoreactive 
protein in membranes from human platelets. These results 
were confirmed with an affinity-purified preparation of an 
antiserum directed toward the amino terminus of G,,, P-961 
(Fig. 5). In contrast to recent reports (38, 39), we have not 
been able to detect G,, in either the cytosolic (high speed 
supernatant) fractions of these tissues (results not shown) or 
in membranes derived from liver or erythrocytes (Fig. 5). 
Bovine brain was selected as the starting material for the 
purification of G,. 
The purification of G, from bovine brain required five 
chromatographic steps and yielded only small amounts of 
protein (Tables II and III). Recoveries at each step were 
judged to be >50% by immunoblot analysis of the fractions 
obtained. The omission of AMF from the buffers used in the 
purification led to a dramatic loss in recovery; under these 
conditions, the protein eluted in the void volume of the AcA 
34 column, and it adsorbed so tightly to the heptylamine- 
Sepharose resin that urea was required for elution. It appears 
that AMF stabilizes G, during purification; this is likely due 
to the ability of Mg2f to stabilize the GDP-bound form of the 
protein (see below). 
Since the interaction of a G protein (Y subunit with guanine 
nucleotides is a crucial facet of its function, analysis of the 
intrinsic ability of the protein to exchange GDP for GTP and 
to hydrolyze the bound triphosphate provides a starting point 
for its characterization. The divalent cation Mg2+ also serves 
an important role in this process (34, 40). Initial studies of 
the ability of G, to bind GTPyS and to hydrolyze GTP yielded 
low stoichiometries and rates, respectively, for these two 
processes. However, one consistent observation was that M$+ 
at concentrations in excess of 1 mM greatly inhibited both 
phenomena. Since this behavior is similar to that observed 
op 
6 
; Bovine Brain 
:, p,i, NG108 
is s49 
4 Adrenal Medulla 
2 3, ’ Adrenal Cortex 
*++., Rabbit Liver 
4: 
Human Erythrocyte 
Human Platelet 
g .c 
( 
Human Placenta 
Bovine Atria 
Bovine Ventricle 
r% 
FIG. 5. Immunoblot analysis of membrane proteins resolved 
by SDS-polyacrylamide gel electrophoresis. Membrane frac- 
tions (50 pg of protein) from the tissues or cell lines indicated were 
processed by SDS-PAGE, and the resolved proteins were transferred 
to nitrocellulose. Adrenal samples were bovine. Immunoblot analysis 
was performed as described under “Experimental Procedures” using 
affinity-purified P-961 antiserum (Table I) at a 1:500 dilution. Film 
was exposed to blots for 12 h using an intensifying screen. The rG,, 
standard contained 15 ng of the purified protein. 
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Properties of G, 2387 
with ras proteins (41), we examined more closely the polypep- 
tide composition of our purified samples of bovine brain G,. 
By increasing the quantity of protein analyzed and by staining 
gels with Coomassie Blue rather than silver, we visualized a 
contaminant in the preparations with an apparent M, of 
26,000 (results not shown). By transferring the proteins to 
nitrocellulose and incubating with [cu-~‘P]GTP (42), we de- 
tected binding of this nucleotide to the 26-kDa protein, sug- 
gesting that it was one of the many GTP-binding proteins in 
this size range. Binding of GTP to the 40-kDa protein was 
not observed with this technique; however, attempts to dem- 
onstrate binding to G,, and Gi, were also unsuccessful. Several 
attempts were made to resolve the two species chromato- 
graphically, but this was never completely successful. Since 
the presence of at least two GTP-binding proteins in the 
sample made analysis of protein-nucleotide interactions dif- 
ficult, we attempted to express the cDNA for rG,, in E. coli; 
this bacterium contains no GTP-binding proteins that are 
detectable with the GTP overlay technique (results not 
shown). We are exploring the possibility that the apparent 
association of G, with a small GTP-binding protein is func- 
tionally significant. 
Guanine Nucleotide-binding Characteristics of rG,,-Trans- 
formation of plasmid NpT7-5/G, into the BL-21/DE3 strain 
of E. coli and induction with isopropyl P-D-thiogalactopyran- 
oside resulted in the accumulation of immunoreactive protein 
in these cells to concentrations of about 1 mg/liter of culture; 
approximately 20% of this protein was present in the high 
speed supernatant of the cell extract. The protocol summa- 
rized in Tables II and III allows the rapid purification of rG,,, 
from this supernatant, and immunoblot analysis is not re- 
quired to follow the elution of the protein from chromato- 
graphic supports. 
Confirmation that G, is in fact a guanine nucleotide-binding 
protein came from analysis of the binding of GTPyS to the 
two forms of rGz,, purified from the E. coli expression system. 
Stoichiometry of binding was approximately 0.5 mol/mol, 
based on the protein determination. Time courses for the 
binding of nucleotide to both the clipped (mono-S:l) and 
intact (mono-S:2) forms of rGz,, in the presence of 500 nM 
free Mg2’ are shown in Fig. 6. Both forms exhibit essentially 
identical rates of nucleotide binding-O.02 mini. However, 
in the presence of 5 mM free Mg2+, this rate is reduced 
dramatically. Under these conditions, the rate of GTP# 
binding to the intact form of rG,, is less than 0.001 min-‘. 
The effect of Mg2+ on the rate of nucleotide binding to the 
intact form of rG,, was examined in more detail (Fig. 7). 
Binding is optimal in the nM to low pM range of Mg*+ 
concentrations, but the rate falls off dramatically as Mg*+ 
concentrations exceed 50 pM. This inhibition of nucleotide 
binding by Mg2+ is due to a stabilization of the GDP-bound 
form of the protein, since the same behavior is observed if 
one examines the rate of dissociation of GDP rather than the 
association of GTPyS (results not shown). Thus, as with 
other members of the G protein family, the dissociation of 
GDP from G,, limits the rate of nucleotide exchange. Milli- 
molar concentrations of Mn2+ inhibit nucleotide binding to 
an extent similar to that of Mg2+; similar concentrations of 
Ca2+ had only a small effect (results not shown). 
The ability of various purine and pyrimidine nucleotides to 
compete for the binding of GTPyS to rGzu was also examined 
(Table IV). Of the nucleotides tested (at a IOO-fold M excess 
over GTPrS), only guanine nucleotides and, to a lesser extent, 
ITP were effective. The capacity of ITP to compete for the 
guanine nucleotide-binding site on other G protein 01 subunits 
is well documented (43). 
0 
2 
t +,:E o~~Lo-0 
o 4~~0.0.q-o-, 
0 40 60 80 100 120 140 20 160 
Time (min) 
FIG. 6. Time course of GTP-yS binding to rG,,. Binding was 
carried out at 30°C in 50 mM Hepes (pH 7.6), 1 mM EDTA, 1 mM 
DTT, 0.5 pM GTPrS (20,000 cpm/pmol), and 0.05% Lubrol in a total 
volume of 60 ~1. Experiments using the intact (0) and amino-terminal 
clipped (+) forms of rG,, were conducted at 500 nM free Mg*+. A 
second time course using the intact form of rG,,, (3) was conducted 
at 5 mM Mfl. Incubations with the two forms of rG,, (3 pmol of 
protein/point) were conducted for the indicated times, reactions were 
terminated, and bound nucleotide was determined as described under 
“Experimental Procedures.” Data shown represent the mean of trip- 
licate determinations from a single experiment, which is representa- 
tive of four such experiments. 
o‘“o 
-Log Free Mg*+ (M) 
FIG. 7. Effect of Mg2+ on the initial rate of GTPyS binding 
to rG,. The assay conditions were as described in the legend to Fig. 
6, except that the protein was gel filtered (G-50 resin) into buffer 4 
(see “Experimental Procedures”) prior to the assay. Reaction mix- 
tures were supplemented with MgSO, such that the indicated concen- 
trations of free Mg2+ were achieved. The zero Mg2+ point was deter- 
mined with 5 mM EDTA in the assay mixture. Incubations with rG,, 
(0.8 pmol) were for 20 min; reactions were then terminated, and 
bound nucleotide was determined. Data shown represent the mean of 
triplicate determinations from a single experiment, which is repre- 
sentative of three such experiments. 
GTPase Activity of rG,,-As shown in Fig. 8A, rG,, pos- 
sesses intrinsic GTPase activity. However, the protein ex- 
hibits an extremely slow steady-state rate of GTP hydrolysis 
(k c 0.005 min-‘), and there is a lag in the approach to this 
value (tlh approximately 7 min). The lag in the release of 
phosphate (defined as the extrapolation of the steady-state 
release of P, to the abscissa) is equal to (k,., + k&-l (33); 
calculation of kcat from this relationship yields a value of 0.04 
min-‘, given a lag of 17 min and a value of k,ff( k,, for GTP7.S) 
of 0.02 min-‘. 
A related method for determining k,.* is to examine the rate 
of approach to steady state of GTP binding (Fig. 8, B and C). 
The apparent k,, for [T-~‘P]GTP is equal to kcat + k,ff since 
the label is released upon hydrolysis. The data of Fig. 8B 
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Properties of G, 
TABLE IV 
Ability of nucleotides to compete for GTPyS binding to rG,, 
Assays were conducted as described in the legend to Fig. 5 and 
contained 500 nM free Me, 0.5 PM GTPyS, and the indicated 
nucleotide as competitor (50 FM). Reactions were terminated at 15 
min, and bound GTPrS was determined. Results are reported as 
binding relative to the value with no competing nucleotide (100; 0.60 
pmol). 
Competing nucleotide GTPyS bound (relative) 
None 
ATP 
i%cNH)p” 
CTP 
UTP 
GTP 
GDP 
GTP-IS 
100 
14 
88 
8 
88 
82 
<5 
<5 
<5 
’ App(NH)p, adenosine 5’-(P,y-imido)triphosphate. 
indicate that the apparent k,, for [T-~‘P]GTP is 0.09 min-‘, 
corresponding to a k,,, of 0.07 min-‘. The rate and extent of 
[w~‘P]GTP binding were also measured. The k,, for [a-32P] 
GTP is equal to that shown above for GTP+-0.02 min-‘. 
Assessment of the extent of binding of [-Y-~*P]GTP uers’sus [a- 
32P]GTP permits determination of the fractional occupancy 
of rG,, by GTP (that is, the fraction of G,, that contains 
GTP, rather than GDP, in the presence of the triphosphate). 
This fraction is equal to Iz&(k,,, + Iz,ft). For the experiment 
shown in Fig. SC, the value is 0.34; this implies a %.t for rGza 
of about 0.05 min-’ at 30 “C, in good agreement with the 
values estimated above (0.04 mine1 and 0.07 min-‘). This 
value is relatively unaffected by Mp concentration over the 
range of nM to RIM (data not shown). The k,,, for G,, is about 
200-fold slower than those determined for G,, (10) and the 01 
subunits of the Gis and G, (34).’ 
Modification of rG,, by Bacterial Toxins-The deduced 
amino acid sequence of G,, reveals that an isoleucine residue 
replaces the cysteine near the carboxyl terminus that serves 
as the site of ADP-ribosylation of Gi and G,. Thus, it has 
been assumed that G,, is refractory to this modification. 
Consistent with this assumption, we have been unable to 
ADP-ribosylate either the purified protein from bovine brain 
or rG., by appropriate treatment with pertussis toxin and 
NAD (Fig. 9). In both cases, ADP-ribosylation of G, con- 
ducted in parallel proceeded smoothly. Similar results were 
obtained when we attempted to ADP-ribosylate G, with NAD, 
cholera toxin, and ADP-ribosylation factor (a protein neces- 
sary for ADP-ribosylation of G,, by cholera toxin). Cholera 
toxin did not modify either bovine brain G,, or rG,,, but rG,, 
was efficiently modified in parallel experiments. Although the 
arginine residue that has been identified as the site of modi- 
fication by cholera toxin (44) is conserved in G,,, this residue 
is also present in other members of this family that cannot 
be modified by this toxin. 
rG,, Interacts with (37 Subunits-The observation that G, 
from bovine brain copurified with the @y subunit complex 
that is associated with other G,polypeptides (Fig. 1) suggested 
that G,, was also capable of associating with & to form a 
heterotrimer. This possibility was examined by determining 
the ability of purified bovine brain & to inhibit the binding 
of GTPrS to purified rG,,; Py is known to stabilize the GDP- 
bound form of other G protein cr subunits (33). The data 
shown in Fig. 10 reveal that /3-y does inhibit nucleotide binding 
to rG,,. However, the effect is a modest one and requires 
rather high concentrations of P-y. Several lines of evidence 
support the notion that the amino terminus of a G protein (Y 
Time (mln) 
FIG. 8. Determination of It.., for rG,. A, GTPase activity of 
rG,. Conditions were as described in the legend to Fig. 6, except that 
the GTPrS in the incubation mixture was replaced by 0.5 PM Ir-3’P] 
GTP. Reaction mixtures (50 ~1) contained 5 pmol of rG,,. At the 
indicated times, reactions were terminated, and released 32Pi was 
quantitated as described under “Experimental Procedures.” Data 
shown represent the mean of duplicate determinations from a single 
experiment, which is representative of two such experiments. B, time 
course of [or-‘*P]GTP and [+y-32P]GTP binding to rG,,. Conditions 
were as described in the legend to Fig. 6, except that the GTPrS in 
the incubation mixture was replaced with either [n-32P]G’I’P or [y- 
‘*P]GTP (1 pM). Reactions were terminated at the indicated times 
and bound nucleotide determined. The data are plotted as a percent 
of the maximum binding (B,.,) (end point) for each assay, which was 
3.55 and 1.21 pmol for [w~‘P]GTP and [r-32P]GTP, respectively. 
Data shown represent the mean of triplicate determinations from a 
single experiment, which is representative of three such experiments. 
C, the data obtained in the experiment described in part B were 
replotted as a percentage of the B,, determined for [w~‘P]GTP; 
determination of the B,., for [-y-32P]GTP thus yields the fractional 
occupancy of rG,, by GTP (see “Results”). 
subunit is important for interactions with 07 and that removal 
of the amino terminus disrupts such interactions (45, 46). 
Thus, the observation that the clipped form of rG,,, which is 
missing the amino terminus, does not show any inhibition of 
nucleotide exchange by /3r supports the conclusion that rGtn 
can in fact interact with @r. It is probably not surprising that 
the effect on nucleotide exchange is so modest, since this rate 
for rGzn is already more than lo-fold lower than those of other 
ct subunits. This result, coupled with the copurification of G., 
and fir from bovine brain, strongly implies that G, is a 
heterotrimer in its basal state. 
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Properties of G, 
A 
Pertussis Cholera 
Toxin Toxin 
Go GZ rGs GZ 
52kDa- * 
39kDa- or: 
B 
Pertussis Cholera 
Toxin Toxin 
rGs rGZ 
52kDa-+ 
39kDa+ 
I 
FIG. 9. ADP-ribosylation of G. by bacterial toxins. A, puri- 
fied preparations of G, (0.7 pmol), the 52-kDa form of recombinant 
G,, (rG,, 0.5 pmol), and bovine brain G, (5 pmol for pertussis toxin, 
0.5 pmol for cholera toxin) were treated with [32P]NAD and either 
pertussis toxin or cholera toxin (in the presence of ADP-ribosylation 
factor), and the reaction mixtures were processed by SDS-PAGE and 
autoradiography. B, the identical experiment was performed except 
that purified rG,,, was utilized instead of bovine brain G,. The quan- 
tities of each protein treated were: G,, 0.2 pmol; rG,,, 1.0 pmol; rGzn 
(pertussis toxin), 1.4 pmol; rG,, (cholera toxin), 3.0 pmol. Experi- 
ments with recombinant proteins were performed in the presence of 
a 3-lo-fold M excess of the @r subunit complex purified from bovine 
brain. 
DISCUSSION 
We have expressed the cDNA that encodes the (Y subunit 
of G, in E. coli and have developed a rapid and relatively 
simple procedure for purification of the recombinant protein. 
Purified rG,,, displays properties that set it apart from other 
G protein cy subunits. The basal rate of guanine nucleotide 
exchange is extremely slow (lz = 0.02 min-’ at 30 “C) in the 
absence of Mg’+, and perhaps more interesting, this rate is 
strongly suppressed by the metal. This effect of Mg2’, al- 
though not seen with other G proteins, is qualitatively similar 
to that observed with the ras proteins (41). Quantitatively, 
however, the proteins differ markedly in these rates. The rate 
of dissociation of GDP from ras is about 1 min-’ at low 
concentrations of Mg2+ and is decreased to 0.02 min-’ in the 
presence of mM concentrations of the ion (at 37 “C). 
Another major difference between rGz, and other G protein 
(Y subunits is the extremely slow rate of hydrolysis of GTP by 
rG,,,. The k,., for GTP hydrolysis by G,,, G,,,, and the Gi,s at 
30 “C is in the range of 10 min-’ (10, 34),* or 200 times faster 
0 I I I I 
I 
20 50 10 25 50 
FIG. 10. Effect of @y on the initial rate of binding of GTPrS 
to both the clipped and intact forms of rG,. The clipped form 
(+) and the intact form (0) of rG,, were incubated on ice for 30 min 
in a solution containing 50 mM NaHepes (pH 8.0), 1 mM EDTA, 1 
mM DTT. 1 mM MgC$, 50 nM GDP, 0.1% Lubrol, and the indicated 
amount of purified @y in a total volume of 30 el. The mixtures were 
then diluted 2-fold with a solution containing GTP-yS such that the 
final concentrations of components were as described in the legend 
to Fig. 6. The samples were incubated for 20 min; reactions were then 
terminated, and bound nucleotide was determined. The results are 
expressed as the fraction of GTP-yS bound compared with the value 
measured in the absence of &, which was 0.36 and 0.18 pmol for the 
clipped and intact forms of rG,,, respectively. Data shown represent 
the mean of triplicate determinations from a single experiment, which 
is representative of two such experiments. 
than that determined here for rGzn (0.05 min-‘). Thus, once 
GTP binds to rG,,,, the tlh for hydrolysis (and presumably for 
deactivation of the protein) is IO-12 min, compared with a 
few seconds for the other G protein cy subunits. Again, this 
behavior is similar to that observed with the ras proteins, 
which exhibit a k,,, for GTP hydrolysis of 0.02 min-’ at 37 “C 
(47). 
Previous results from this laboratory have demonstrated 
that the interactions of guanine nucleotide with recombinant 
G protein (Y subunits are essentially identical to those of their 
counterparts purified from mammalian tissues’ (10). Thus, 
we feel that the characteristics of rGEn described above accu- 
rately reflect the behavior of the mammalian protein. This 
conclusion is strengthened by experiments recently conducted 
with an altered form of rG,,. As mentioned earlier, G,, is the 
only member of the G protein family to date to exhibit 
divergence of amino acid sequence in the first portion of the 
guanine nucleotide-binding domain. When the sequence of 
this region of G,, is changed to that present in G,, by site- 
directed mutagenesis, the altered protein (mutant rG,,) shows 
a 50-fold reduction in Iz~,,, compared with its wild-type coun- 
terpart.3 
Although the fraction of rGza which contains GTP at steady 
state is considerably lower than that observed with ras under 
similar conditions (0.3 versus 0.9), this difference is due 
mainly to the very slow rate of nucleotide exchange for rGZn. 
Presumably, there exists in vivo an exchange factor (recep- 
tor?) that serves to increase the rate of exchange of guanine 
nucleotides on the protein. The extremely sluggish rate of 
GTP hydrolysis by G,, would then result in a signal with a 
long lifetime. This slow Izccatprompts speculation on the exist- 
ence of a GTPase-activating protein for G,, similar to those 
recently described for ras and related proteins (48, 49). The 
‘G. Santoyo, P. J. Casey, and A. G. Gilman, unpublished obser- 
vations. 
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GTPase-activating proteins apparently enhanced deactiva- 19. Matsuoka, M., Itoh, H., Kozasa, T., and Kaziro, Y. (1988) Proc. 
tion of these proteins by increasing their rate of hydrolysis of Natl. Acad. Sci. U. S. A. 85, 5384-5388 
bound GTP; GTPase-activating proteins may be the actual 20. Jurnak, F. (1985) Science 230,32-36 
effecters that are regulated by the ras proteins. Demonstration 
21. De Vos, A. M., Tong, L., Milburn, M. V., Matias, P. M., Jancarik, 
J., Noguchi, S., Nishimura, S., Miura, K., Ohtsuka, E., and 
of a similar relationship for G, might facilitate identification Kim, S.-H. (1988) Science 239,888-893 
of the next protein in its signaling pathway. 22. Tong, L., De Vos, A. M., Milburn, M. V., Jancarik, J., Noguchi, 
We have been unable to ADP-ribosylate bovine brain G, or S., Nishimura, S., Miura, K., Ohtsuka, E., and Kim, S.-H. 
rGza with pertussis or cholera toxin. Thus, any signaling 
(1989) Nature 337, 90-93 
23. Barbacid, M. (1987) Annu. Reu. Biochem. 56, 779-828 
systems under the control of G, should be refractory to 24. Graziano, M. P., and Gilman, A. G. (1989) J. Biol. Chem. 264, 
disruption by either of these proteins. Candidate systems 15475-15482 
include some pathways for the regulation of phosphoinositide- 25. Sternweis, P. C., and Robishaw, J. D. (1984) J. Biol. Chem. 259, 
specific phospholipase C (16, 50) and substance P-induced 13806-13813 
inhibition of K+ channels in brain neurons (17). The availa- 
26. Mumby, S. M., Pang, I.-H., Gilman, A. G., and Sternweis, P. C. 
(1988) J. Biol. Chem. 263, 2020-2026 
bility of purified rGza will facilitate studies of its possible 27. Roof, D. J., Applebury, M. L., and Sternweis, P. C. (1985) J. Biol. 
involvement in these and other signaling systems. Chem. 260, 16242-16249 
28. Casey, P. J., Graziano, M. P., and Gilman, A. G. (1989) Biochem- 
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